Search
for
Sort by
Research 31–60 of 1000+
- 546 Epidermal growth factor receptor as a key regulator of the immune privilege
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Cutaneous side-effects of EGFR inhibitors and their management.
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Treatment of acne with intermittent isotretinoin, cohort study
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- “PRIDE” Complex
- Pathogenesis and management of TRPV3-related Olmsted syndrome
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Molecular biology of hair morphogenesis: Development and cycling
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- Skin Deep and Deeper: Multiple Pathways in Basal Cell Carcinogenesis
- Syntaxin 9 is Enriched in Skin Hair Follicle Epithelium and Interacts With the Epidermal Growth Factor Receptor
- The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
- Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development
- Urokinase is a Positive Regulator of Epidermal Proliferation In Vivo